NCT00443508View on ClinicalTrials.gov

Reduction or Discontinuation of CNI's With Conversion to Everolimus-Based Immunosuppresion

PHASE4UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2007

Study Completion Date

February 28, 2010

Conditions
Kidney Diseases
Interventions
DRUG

adding Certican to therapy

DRUG

reducing Tacrolimus

Trial Locations (1)

49202

RECRUITING

Transplantation department, rabin Medical Center, Petah Tikva

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Rabin Medical Center

OTHER